| Model Number |
VNMC3737C182TU |
| Medical Device Problem Code |
Leak/Splash (1354)
|
| Health Effect - Clinical Codes |
Vascular Dissection (3160); No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
08/24/2021
|
|
Type of Reportable Event
|
Death
|
|
Additional Manufacturer Narrative
|
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event or Problem Description
|
|
Valiant navion stents were implanted in the endovascular treatment of a unknown sized taa and dissection. it was reported that corelab have reviewed ct imaging and have identified a type ia endoleak on the stent graft with sn (b)(4).No fracture, stent ring enlargement/migration were noted.The maximum aortic diameter was 54.6mm. the cause of the event can not be determined. no additional clinical sequalae were provided and the patient will be monitored.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information received; it was reported the patient presented with a contained rupture of type a aortic dissection approximately 4 years and 8 months after the index procedure.The patient underwent surgery but suffered a pulseless electrical activity (pea) arrest in the intense care unit (icu).Following the arrest, comfort care was initiated at the family's request.The patient expired on the same date.The cause of death was assessed as aortic-related due to the dissection.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|